Intrasinus tPA for Successful Treatment of Extensive Dural Sinus Thrombosis in a Young Patient With COVID-19: Rationale and Protocol

Abstract

Keywords

cerebral venous thrombosis dural sinus thrombosis COVID-19 tPA

Get full access to this article

View all access options for this article.

References

Helms

Tacquard

Severac

, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098.

Kremer

Lersy

Anheim

, et al. Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. 2020;95(13):e1868–e1882.

Chougar

Mathon

Weiss

Degos

Shor

. Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1377–1379.

Poillon

Obadia

Perrin

Savatovsky

Lecler

. Cerebral venous thrombosis associated with COVID-19 infection: causality or coincidence? J Neuroradiol. 2020;S0150–9861(20)30167–X.

Goh

Tan

, et al. Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis. 2020;29(12):105379.

Karanam

Baddam

Pamidimukkala

Vemuri

Byrapaneni

Polavarapu

. Local intrasinus thrombolysis for cerebral venous sinus thrombosis. J Vasc Interv Neurol. 2016;9(2):49–54.